Data integrity considerations in Pharma and Life Sciences
European Pharmaceutical Review
MARCH 12, 2024
If data used to support the safety , efficacy and quality of pharmaceutical products is compromised or unreliable, it can lead to regulatory non-compliance, product recalls, and most importantly, harm to patients who depend on those medications. How can this be mitigated? What is the greatest current challenge in maintaining data integrity?
Let's personalize your content